Skip to content
AwardedFranceGoods€1,000,000,000

AO MEDICAMENTS ANTINEOPLASIQUES ET IMMUNOMODULATEURS (Classe ATC L)

Published
Published 21 February 2025
Deadline
Closed 24 March 2025

Overview

Montant HT estimé pour la durée totale du contrat : 1.0E9 Euro(s) H.T. Les seuils sont exprimés en quantité au sein des documents de la consultation. Consultation lancée par un groupement de commandes. L'accord-cadre sera exécuté par l'émission de bons de commande. Chaque lot fera l'objet d'une attribution séparée. Les prestations sont réglées par des prix unitaires. Les montants estimatifs sont indicatifs et comprennent la totalité des périodes de reconduction. AO MEDICAMENTS ANTINEOPLASIQUES ET IMMUNOMODULATEURS (Classe ATC L) Du 1er juin 2025 au 31 mai 2025, reconductible 2 fois 12 mois jusqu'au 31 mai 2028

Key details

Country
France
Status
Awarded
Category
Goods
Estimated value
€1,000,000,000
Procedure
Open
Published
21 February 2025
Deadline
Closed
Classification (CPV)
Antineoplastic and immunomodulating agents

Award outcome

Awarded value
€7,211,503
Award date
27 May 2025
Contract period
1 June 2025 → 31 May 2026
Winners
  • ACCORD HEALTHCARE FRANCE SAS
  • ARROW GENERIQUES
  • EVER Pharma France
  • FRESENIUS KABI FRANCE
  • REDDY PHARMA SAS
  • SANDOZ
  • VIATRIS SANTE
  • Zentiva France

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    2 June 2025

  2. Contract Notice

    21 February 2025

Contracting authority

  • CH de Saint-Brieuc/Paimpol/Tréguier - Etablissement support du GHT d'ARMOR

    Procuring entity

    Saint-Brieuc, France

    eu: 57261

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: AO MEDICAMENTS ANTINEOPLASIQUES ET IMMUNOMODULATEURS (Classe ATC L) — won by ACCORD HEALTHCARE FRANCE SAS +7 — Skim